A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase
BLOOD CELLS MOLECULES AND DISEASES. Bd. 53. H. 4. 2014 S. 253-260
Erscheinungsjahr: 2014
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Pastores, Gregory M. (Autor)
Petakov, Milan (Autor)
Giraldo, Pilar (Autor)
Rosenbaum, Hanna (Autor)
Szer, Jeffrey (Autor)
Deegan, Patrick B. (Autor)
Amato, Dominick J. (Autor)
Mengel, Eugen (Autor)
Tan, Ee Shien (Autor)
Chertkoff, Raul (Autor)
Brill-Almon, Einat (Autor)
Zimran, Ari (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
